These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 401355)

  • 1. Early detection of high risk subjects in affective disorders.
    Mendlewicz J
    Prog Neuropsychopharmacol; 1979; 3(5-6):613-24. PubMed ID: 401355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of relapses in subjects with mood disorder on lithium treatment.
    Gasperini M; Scherillo P; Manfredonia MG; Franchini L; Smeraldi E
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):103-10. PubMed ID: 8364346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who responds to prophylactic lithium therapy?
    Abou-Saleh MT
    Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-types of bipolar affective disorder with particular regard to bipolar II.
    Dunner DL
    Psychiatr Dev; 1983; 1(1):75-85. PubMed ID: 6425825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a loss of efficacy of lithium in patients treated for over 20 years?
    Berghöfer A; Müller-Oerlinghausen B
    Neuropsychobiology; 2000; 42 Suppl 1():46-9. PubMed ID: 11093072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early mood swings as symptoms of the bipolar prodrome: preliminary results of a retrospective analysis.
    Ozgürdal S; van Haren E; Hauser M; Ströhle A; Bauer M; Assion HJ; Juckel G
    Psychopathology; 2009; 42(5):337-42. PubMed ID: 19672137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood-independent aberrancies in associative processes in bipolar affective disorder: an apparent stabilizing effect of lithium.
    Pons L; Nurnberger JI; Murphy DL
    Psychiatry Res; 1985 Apr; 14(4):315-22. PubMed ID: 3860884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remitted affective disorders and high familial risk of affective disorders associate with aberrant intestinal microbiota.
    Vinberg M; Ottesen NM; Meluken I; Sørensen N; Pedersen O; Kessing LV; Miskowiak KW
    Acta Psychiatr Scand; 2019 Feb; 139(2):174-184. PubMed ID: 30374951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine and lithium carbonate in the treatment of refractory affective disorders.
    Keisling R
    Arch Gen Psychiatry; 1983 Feb; 40(2):223. PubMed ID: 6401989
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacotherapy of mood disorders.
    Thase ME; Denko T
    Annu Rev Clin Psychol; 2008; 4():53-91. PubMed ID: 18370614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The longitudinal polymorphism of bipolar I disorders and its theoretical implications.
    Marneros A; Roettig S; Roettig D; Tscharntke A; Brieger P
    J Affect Disord; 2008 Apr; 107(1-3):117-26. PubMed ID: 17884177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
    Bowden CL
    J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
    [No Abstract]   [Full Text] [Related]  

  • 16. Tryptophan depletion in lithium-stabilized patients with affective disorder.
    Johnson L; El-Khoury A; Aberg-Wistedt A; Stain-Malmgren R; Mathé AA
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):329-36. PubMed ID: 11806858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.
    Grof P; Alda M; Grof E; Fox D; Cameron P
    Br J Psychiatry Suppl; 1993 Sep; (21):16-9. PubMed ID: 8217062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene.
    Cavazzoni P; Alda M; Turecki G; Rouleau G; Grof E; Martin R; Duffy A; Grof P
    Psychiatry Res; 1996 Sep; 64(2):91-6. PubMed ID: 8912950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage between an X-chromosome marker (deutan color blindness) and bipolar affective illness. Occurrence in the family of a lithium carbonate-responsive schizo-affective proband.
    Baron M
    Arch Gen Psychiatry; 1977 Jun; 34(6):721-5. PubMed ID: 301380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The red blood cell/plasma lithium ratio: marker of biological heterogeneity within bipolar affective illness?
    Rihmer Z; Arató M; Szentistványi I; Bánki CM
    Psychiatry Res; 1982 Apr; 6(2):197-201. PubMed ID: 6806837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.